Purpose: To provide the Cameroon IeDEA stakeholders with an overview of the IeDEA study implementation in Cameroon as well as present the Cameroon IeDEA study 4-year strategic plan. Present at the meeting were representatives from: Albert Einstein College of Medicine, USA Clinical Research Education Networking and Consultancy (CRENC) Directorate of
Tagged as: Cameroon
Global Congestive Heart Failure Registry (GCHF) in Cameroon
Heart failure (HF) is a rapidly increasing disease worldwide and results in major morbidity, mortality and costs. No global HF study has been performed that documents demographics, socioeconomic and clinical factors, diagnostic and management patterns, etiology, biomarkers, co-morbidities, treatments, quality of life, barriers to care and outcomes in all parts
CREOLE Study in Cameroon
Reducing blood pressure to target levels is a major priority in preventing clinical events in hypertension. Although there are many possible combinations of BP-lowering therapies, the best combination for the black population is still a subject of debate. Furthermore, current guideline recommendations are inconsistent and conflicting for black patients. CREOLE stands
The INVICTUS Trial in Cameroon
Stroke is a devastating and decapitating outcome of Atrial Fibrillation (AF). AF affects 1-2% of the general population and it’s the most frequently encountered arrhythmia in clinical practice. Although any valvular pathology can be related to AF, stenotic left-sided valvular lesions (and in particular rheumatic heart disease) have the highest
Cervical Cancer Study in Cameroon
Human immunodeficiency virus-infected (HIV[+]) women have a several-fold increased risk of invasive cervical cancer (ICC) as well as increased risk of cervical pre-cancer. In low- and middle income countries (LMICs), ICC is the 1st or 2nd most common cause of cancer and cancer-related death in women. Rates of ICC and
IeDEA Project in Cameroon
The overall goal of the IeDEA study is to use secondary clinical, laboratory and epidemiologic data from HIV-infected patients in various regions to answer HIV/AIDS and other related co-morbidities research questions that cannot be answered with existing individual cohorts in each country. The IeDEA research consortium makes it possible to
PANACEA Heart Failure Study in Cameroon
Heart failure (HF) is a cardiovascular disease which affects 1 – 2% of adult population over 40 years old. It is one of the leading pathologies among hospitalised patients in sub-Saharan Africa, accounting for over 30% of admissions in specialised cardiac unit. It is associated with many symptoms and clinical
Research Methods Training At The Douala General Hospital
Over three-quarters of deaths from cardiovascular disease (CVD) occur in Low-and-Middle-income-countries, many of which reside in Sub Saharan African region. One of the nine global non-communicable disease (NCD) targets, is to reduce cardiovascular mortality by 25% by the year 2025. Whether this is attainable or not depends largely on the
